'Blood derivatives' diaporamas de présentation

Regulatory and Scientific Issues of Biosimilars

Regulatory and Scientific Issues of Biosimilars . Duu-Gong Wu, Ph.D. Executive Director, PharmaNet Member, FDA Alumni Association DIA China, Beijing, China May 16-18, 2011. Disclosures.

1.01k views • 31 slides

Factors Essential to the Progress of Patient Blood Management

525 views • 29 slides

October 2013

October 2013. OUTLINE. Introduction about the Instituto Butantan Infrastructure at Instituto Butantan Translational medicine at Instituto Butantan. ABOUT US. The Instituto Butantan is a biomedical research and biological product manufacturing center founded in 1901.

349 views • 22 slides

Medication Reconciliation: Obtaining a Best Possible Medication History

Medication Reconciliation: Obtaining a Best Possible Medication History . Objectives. By the end of this session, staff will be able to: Recognize the potential for dangerous medication errors in all clinical encounters Define medication reconciliation

617 views • 16 slides